Do ‘Natural GLP-1’ Supplements Work? The Evidence vs the Drugs

Affiliate links: as an Amazon Associate and through other programs, we earn from qualifying purchases, at no extra cost to you. Learn more.

No supplement comes close to the GLP-1 drugs. In the STEP 1 trial, adults on weekly semaglutide 2.4 mg lost 14.9% of their body weight on average over 68 weeks, against 2.4% on placebo (Wilding et al., 2021). In SURMOUNT-1, tirzepatide produced average losses of 15.0% to 20.9% over 72 weeks, depending on the dose, against 3.1% on placebo (Jastreboff et al., 2022).

Supplements sold as “natural GLP-1” do far less. Compared with control groups, berberine lowered weight by 0.88 kg (about 2 lb) across 23 trials (Elahi Vahed et al., 2026), probiotics by 0.6 kg (Borgeraas et al., 2018) and soluble fiber by 2.5 kg in short trials with very mixed results (Thompson et al., 2017). In STEP 1, semaglutide beat placebo by 12.7 kg (28 lb).

What GLP-1 is and what the drugs do

GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after meals. It helps the pancreas release insulin, lowers glucagon, slows stomach emptying and helps regulate appetite (Holst, 2007). Your own GLP-1 has a half-life of one to two minutes, largely because the enzyme DPP-4 breaks it down; semaglutide resists this and has a half-life of about 160 hours, which allows weekly injections (Müller et al., 2019). Tirzepatide also acts on a second gut-hormone receptor, GIP (Jastreboff et al., 2022). A supplement can at most nudge your own short-lived GLP-1.

Both are prescription drugs. The FDA approved tirzepatide for weight management (as Zepbound) in adults with a BMI of 30 or more, or 27 or more with a weight-related condition (FDA, 2023). In STEP 1, 4.5% of people on semaglutide quit over digestive side effects, against 0.8% on placebo (Wilding et al., 2021); a year after stopping, participants had regained two-thirds of the weight they lost (Wilding et al., 2022).

What “natural GLP-1” supplements have shown in people

“GLP-1” supplements usually contain berberine, fiber, probiotics or plant extracts said to raise your own GLP-1. Here is what has been measured in people.

Berberine

Berberine, a yellow compound from plants such as barberry and goldenseal, is often marketed as “nature’s Ozempic”. It raised GLP-1 in rats and in lab-grown human gut cells (Yu et al., 2010), but our PubMed search (October 2026) found no randomized trial in people that measured GLP-1 after berberine.

• Weight: 0.88 kg more loss than control across 23 trials; the reviewers noted common problems with blinding and randomization (Elahi Vahed et al., 2026).
• Blood sugar: in 20 placebo-controlled trials with 1,761 people, fasting glucose fell by about 9 mg/dL and HbA1c by about 0.4 percentage points, with larger fasting-glucose drops in people with diabetes (Zhao et al., 2023).
• Cholesterol: in 18 placebo-controlled trials with 1,788 people taking 900–1,500 mg a day, mostly in China, LDL cholesterol fell by about 18 mg/dL and triglycerides by about 30 mg/dL (Blais et al., 2023).

Safety: digestive side effects affected 2–23% of people on berberine and 2–15% on placebo, with no serious adverse events (Blais et al., 2023). Interactions matter more:

• Diabetes medicines, including metformin: blood-sugar effects can add up, and a goldenseal extract standardized to berberine cut metformin levels by 23% in healthy adults (Nguyen et al., 2021), less in people with type 2 diabetes (Nguyen et al., 2025).
• Drugs broken down by CYP3A4, CYP2D6 or CYP2C9: after two weeks of 300 mg three times a day, healthy men had 40% higher levels of midazolam, a CYP3A4 test drug, and lower CYP2D6 and CYP2C9 activity (Guo et al., 2012).
• Pregnancy and breastfeeding: the NIH’s National Center for Complementary and Integrative Health (NCCIH) says pregnant or breastfeeding women should not use goldenseal and that its berberine can be harmful to newborns (NCCIH).

Doses and timing are in our complete berberine guide and the supplement dosage chart.

Fiber and psyllium

Fermentable fiber can raise GLP-1: in a trial of 10 healthy adults, those given 16 g of prebiotic fiber a day for two weeks had higher GLP-1 after a meal and less hunger than those on placebo (Cani et al., 2009). Psyllium, by contrast, forms a gel and is not fermented.

• Weight: isolated soluble fiber beat placebo by 2.52 kg in 12 trials of 2 to 17 weeks, with large differences between studies (Thompson et al., 2017). For psyllium alone, 22 trials showed no significant change (Darooghegi Mofrad et al., 2020), while 6 trials analyzed by a psyllium maker’s employees showed 2.1 kg more loss (Gibb et al., 2023). Glucomannan did no better than placebo (Onakpoya et al., 2014).
• Fullness: only 39% of 107 short-term fiber tests reduced appetite, and 22% reduced how much people ate (Clark and Slavin, 2013).
• Blood sugar: in people treated for type 2 diabetes, psyllium before meals lowered fasting glucose by 37 mg/dL and HbA1c by 0.97 points, with no effect at normal blood sugar; the maker’s staff also led this analysis (Gibb et al., 2015).

Safety: gas and bloating are common at first. Psyllium, glucomannan and guar gum can swell and cause choking without enough liquid; FDA rules require drug products made with them to carry a choking warning and to say each dose should be taken with at least 8 ounces of water (21 CFR 201.319). Types and amounts are in our fiber supplement guide.

Probiotics and Akkermansia

• Common probiotics: 0.60 kg more weight loss than placebo across 15 trials of 3 to 12 weeks (Borgeraas et al., 2018), an effect the NIH Office of Dietary Supplements (ODS) calls small and of questionable clinical significance (NIH ODS).
• Akkermansia muciniphila: in the first human trial (32 of 40 adults with overweight or obesity and insulin resistance finished), three months of pasteurized Akkermansia improved insulin sensitivity by about 29% versus placebo; weight fell 2.27 kg more, a difference that was not statistically significant (Depommier et al., 2019).
• A five-strain formula with Akkermansia, tested by its developer in 76 adults with type 2 diabetes, lowered HbA1c by 0.6 points versus placebo over 12 weeks (Perraudeau et al., 2020).

Safety: side effects are usually mild, such as gas; rare serious infections have occurred, mainly in severely ill or immunocompromised people (NIH ODS). Strains and forms are in our probiotic guide.

Yerba mate and curcumin

• Yerba mate: raised GLP-1 in mice (Hussein et al., 2011), but three servings of mate tea a day for 8 weeks left GLP-1 and weight unchanged in 52 normal-weight adults (Bravo et al., 2025), and 13 trials showed no significant effect on BMI, with insomnia and fast heartbeat among reported side effects (Li et al., 2025).
• Curcumin: 0.82 kg less weight in a network meta-analysis of 111 trials, with moderate-certainty evidence (Shahinfar et al., 2023). One 24-week trial of 500 mg a day in 80 people with fatty liver found higher GLP-1 and 2.6 kg more weight loss than placebo (He et al., 2024). NCCIH warns that highly absorbable curcumin may harm the liver and that turmeric supplements may be unsafe in pregnancy (NCCIH). See our turmeric and curcumin review.

The evidence at a glance

Red flags in GLP-1 supplement marketing

• “Nature’s Ozempic” or “works like GLP-1 shots”: no supplement has come close in trials, supplements need no FDA approval before sale, and makers may not promote them to treat, cure or prevent disease (NIH ODS).
• Fast, effortless or permanent weight loss: the Federal Trade Commission (FTC) lists seven claims that experts say cannot be true, including losing 2 pounds or more a week for a month without diet or exercise, and losing weight by wearing a product or rubbing it into the skin (FTC).
• GLP-1 patches and gels: a 2026 review of 24 “natural GLP-1” patches and one gel, with an average of 7 ingredients each, concluded that all of them were illegal, because dietary supplements must be swallowed (White et al., 2026).
• “All-natural” products with glowing reviews: the FDA warns that many weight-loss pills, teas and supplements are likely to contain dangerous hidden ingredients (FDA), and the FTC says scammers use fake news stories, altered photos and fake reviews (FTC).
• Compounded or “research” semaglutide sold as “the same as Ozempic”: these are unapproved drugs, not supplements. By May 31, 2026, the FDA had 990 adverse-event reports for compounded semaglutide and more than 730 for compounded tirzepatide (FDA), and in March 2026 it warned 30 telehealth companies over claims that compounded versions equal approved drugs (FDA).

What works without a prescription

Lifestyle changes are the basis of long-term weight loss (NIH ODS), and losing 5% to 10% of body weight through diet and exercise has been linked to lower cardiovascular risk (FDA, 2023).

• A calorie deficit plus activity: in the Diabetes Prevention Program, 3,234 adults with raised blood sugar aimed to lose at least 7% of their weight and exercise at least 150 minutes a week; over an average of 2.8 years, they developed type 2 diabetes 58% less often than the placebo group (31% less with metformin) (Knowler et al., 2002).
• More protein: in 24 trials of reduced-calorie diets, higher-protein versions gave 0.79 kg more weight loss and kept 0.43 kg more lean mass than standard-protein diets with the same calories (Wycherley et al., 2012). See how much protein to eat for weight loss.
• Fiber from food: in long-term observational studies, people who ate the most fiber had 15% to 30% lower rates of death, heart disease, stroke and type 2 diabetes than those who ate the least, with the largest benefit at 25 to 29 g a day (Reynolds et al., 2019).
• Regular exercise: federal guidelines advise adults to get 150 to 300 minutes of moderate activity a week, plus muscle-strengthening on 2 or more days (Physical Activity Guidelines for Americans).

When to talk to a doctor

• Before taking berberine with metformin, another diabetes medicine or any prescription drug.
• If you are pregnant or breastfeeding, or have high blood pressure, diabetes, or liver or heart disease (NIH ODS).
• If your BMI is 30 or more, or 27 or more with a weight-related condition: these are the groups in which the prescription drugs were tested, and a doctor can go over all the options.
• Before buying compounded, online or “research” semaglutide or tirzepatide.
• If you have a weakened immune system (before probiotics) or liver problems (before curcumin).

If you still want to try berberine or psyllium

1. Buy single ingredients: plain berberine HCl or psyllium husk, not a “GLP-1” blend that hides each dose.
2. Match trial amounts: berberine trials used 900–1,500 mg a day (Blais et al., 2023), which our dosage chart splits into 500 mg two or three times a day with meals; psyllium weight trials averaged 10.8 g a day just before meals (Gibb et al., 2023), each dose with a full glass of water.
3. Look for a quality seal: USP, NSF or ConsumerLab.com seals show that a product contains what the label says without harmful contaminants, not that it is safe or works (NIH ODS).

Browse berberine 500 mg on Amazon

Browse psyllium husk on Amazon

Sources

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. PMID 33567185
2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. PMID 35658024
3. Elahi Vahed I, Shahir-Roudi E, Nojumi S, et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes (Lond). 2026;50(1):53-73. PMID 41310257
4. Borgeraas H, Johnson LK, Skattebu J, Hertel JK, Hjelmesaeth J. Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2018;19(2):219-232. PMID 29047207
5. Thompson SV, Hannon BA, An R, Holscher HD. Effects of isolated soluble fiber supplementation on body weight, glycemia, and insulinemia in adults with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2017;106(6):1514-1528. PMID 29092878
6. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409-39. PMID 17928588
7. Müller TD, Finan B, Bloom SR, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019;30:72-130. PMID 31767182
8. U.S. Food and Drug Administration. FDA approves new medication for chronic weight management. Press release, November 8, 2023. fda.gov
9. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. PMID 35441470
10. Yu Y, Liu L, Wang X, et al. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochem Pharmacol. 2010;79(7):1000-6. PMID 19945441
11. Zhao JV, Huang X, Zhang J, Chan YH, Tse HF, Blais JE. Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Nutr. 2023;153(10):2939-2950. PMID 37598753
12. Blais JE, Huang X, Zhao JV. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Drugs. 2023;83(5):403-427. PMID 36941490
13. Nguyen JT, Tian DD, Tanna RS, et al. Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail. Clin Pharmacol Ther. 2021;109(5):1342-1352. PMID 33174626
14. Nguyen JT, Arian CM, Tanna RS, et al. The Pharmacokinetic Interaction Between Metformin and the Natural Product Goldenseal Is Metformin Dose-Dependent: A Three-Arm Crossover Study in Adults With Type 2 Diabetes. Clin Transl Sci. 2025;18(2):e70120. PMID 39943692
15. Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-7. PMID 21870106
16. National Center for Complementary and Integrative Health. Goldenseal (last updated February 2025). nccih.nih.gov
17. Cani PD, Lecourt E, Dewulf EM, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr. 2009;90(5):1236-43. PMID 19776140
18. Darooghegi Mofrad M, Mozaffari H, Mousavi SM, Sheikhi A, Milajerdi A. The effects of psyllium supplementation on body weight, body mass index and waist circumference in adults: A systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020;60(5):859-872. PMID 30880409
19. Gibb RD, Sloan KJ, McRorie JW Jr. Psyllium is a natural nonfermented gel-forming fiber that is effective for weight loss: A comprehensive review and meta-analysis. J Am Assoc Nurse Pract. 2023;35(8):468-476. PMID 37163454
20. Onakpoya I, Posadzki P, Ernst E. The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. J Am Coll Nutr. 2014;33(1):70-8. PMID 24533610
21. Clark MJ, Slavin JL. The effect of fiber on satiety and food intake: a systematic review. J Am Coll Nutr. 2013;32(3):200-11. PMID 23885994
22. Gibb RD, McRorie JW Jr, Russell DA, Hasselblad V, D’Alessio DA. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. Am J Clin Nutr. 2015;102(6):1604-14. PMID 26561625
23. Code of Federal Regulations. 21 CFR 201.319: Water-soluble gums, hydrophilic gums, and hydrophilic mucilloids as active ingredients; required warnings and directions. ecfr.gov
24. NIH Office of Dietary Supplements. Dietary Supplements for Weight Loss: Fact Sheet for Health Professionals (updated May 18, 2022). ods.od.nih.gov
25. Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-1103. PMID 31263284
26. Perraudeau F, McMurdie P, Bullard J, et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Res Care. 2020;8(1):e001319. PMID 32675291
27. Hussein GM, Matsuda H, Nakamura S, et al. Mate tea (Ilex paraguariensis) promotes satiety and body weight lowering in mice: involvement of glucagon-like peptide-1. Biol Pharm Bull. 2011;34(12):1849-55. PMID 22130241
28. Bravo L, Martínez-López S, Sierra-Cinos JL, Mateos R, Sarriá B. Yerba Mate (Ilex paraguariensis St. Hill.) Tea May Have Cardiometabolic Beneficial Effects in Healthy and At-Risk Subjects: A Randomized, Controlled, Blind, Crossover Trial in Nonhabitual Consumers. Mol Nutr Food Res. 2025;69(15):e70065. PMID 40263915
29. Li D, Yue L, Peng X, et al. Yerba Maté and its impact on glycemic control and metabolic health: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2025;16:1641592. PMID 41244043
30. Shahinfar H, Jayedi A, Torabynasab K, et al. Comparative effects of nutraceuticals on body weight in adults with overweight or obesity: A systematic review and network meta-analysis of 111 randomized clinical trials. Pharmacol Res. 2023;196:106944. PMID 37778464
31. He Y, Chen X, Li Y, et al. Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial. Am J Clin Nutr. 2024;120(1):66-79. PMID 38795741
32. National Center for Complementary and Integrative Health. Turmeric (last updated April 2025). nccih.nih.gov
33. Federal Trade Commission. Gut Check: A Reference Guide for Media on Spotting False Weight Loss Claims (January 2014). ftc.gov
34. White CM, Tai Z, Nuzi K. Transdermal “Natural GLP-1” Dietary Supplements Violate Law and Place Patients at Risk. Ann Pharmacother. 2026;60(8):813-816. PMID 41480958
35. U.S. Food and Drug Administration. Weight Loss Product Notifications (content current as of September 4, 2026). fda.gov
36. Federal Trade Commission, Consumer Advice. The Truth Behind Weight Loss Ads (February 2025). consumer.ftc.gov
37. U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of October 1, 2026). fda.gov
38. U.S. Food and Drug Administration. FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s. Press release, March 3, 2026. fda.gov
39. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. PMID 11832527
40. Wycherley TP, Moran LJ, Clifton PM, Noakes M, Brinkworth GD. Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;96(6):1281-98. PMID 23097268
41. Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019;393(10170):434-445. PMID 30638909
42. U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition (2018). odphp.health.gov
43. NIH Office of Dietary Supplements. Dietary Supplements: What You Need to Know (updated January 4, 2023). ods.od.nih.gov

Related Articles

Berberine vs Metformin: Honest 2026 Comparison Berberine vs metformin: direct comparison study results, key differences in bioavailability and side effects, and who should and shouldn't use berberine.

Berberine Complete Guide 2026: Dosage, Benefits &… Berberine can lower blood sugar, but the trials are small. In one 3-month pilot study (36 adults), it lowered HbA1c about as much as metformin. Talk to your doctor first if you take diabetes medication.

Berberine Benefits: The Natural Metformin (2026… Quick Answer: Berberine activates AMPK (the same enzyme as metformin) and has been compared to metformin in head-to-head trials. Clinical evidence...

Best Weight Loss Supplements 2026: What Actually… Expert Recommendations 2026Best Weight Loss Supplements 2026: What Actually Works (Science) Premium Supplement Stack ⭐⭐⭐⭐4.7/ 5Based on 31,204 reviews⚡...